AMLo Biosciences Gets UKCA Mark for Melanoma Biomarker Test

Source: 360dx, September 2024

NEW YORK — AMLo Biosciences said Tuesday that it has received UK Conformity Assessed (UKCA) marking for its AMBLor test for identifying early-stage melanomas at low risk of progression.
READ THE ORIGINAL FULL ARTICLE